HE staining and immunohistochemical analysis revealed that POSTN knockdown reduced tumor growth and the expression of β-catenin and FOSL1, the GSC marker CD133, and the proliferation marker Ki67 (Fig. 4D). The gene discussed is FOSL1; the disease is neoplasm.